Indigo Garners $56,000,000 Series B Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=465c334a-5486-41e5-a8c1-11a6bc2cf770 - Date
2/18/2016 - Company Name
Indigo - Mailing Address
101 Main Street 14th Floor Cambridge, MA 02142 USA - Company Description
Indigo is pioneering microbial solutions for Symbiotic Agriculture — a new approach to naturally improve plant health and growth by promoting a healthy microbiome. - Website
http://www.indigoag.com - Transaction Type
Venture Equity - Transaction Amount
$56,000,000 - Transaction Round
Series B - Proceeds Purposes
Indigo is trying to first tackle abiotic stress, the type caused by environmental factors such as, say, insufficient water and salty soil. The company is specifically enhancing crops so they get the same yield with less water because most existing technologies are not very good at addressing this issue. In the future, Indigo will take on biotic stresses, which come from living things like weeds and insects. - M&A Terms
- Venture Investor
Flagship Ventures - Venture Investor
Undisclosed
